Research ArticleTheranostics
Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen–Targeted PET Imaging: PSMA-RADS Version 1.0
Steven P. Rowe, Kenneth J. Pienta, Martin G. Pomper and Michael A. Gorin
Journal of Nuclear Medicine March 2018, 59 (3) 479-485; DOI: https://doi.org/10.2967/jnumed.117.195255
Steven P. Rowe
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Kenneth J. Pienta
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Martin G. Pomper
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Michael A. Gorin
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Article Information
vol. 59 no. 3 479-485
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 24, 2017
- Accepted for publication August 1, 2017
- Published online March 1, 2018.
Article Versions
- previous version (September 8, 2017 - 04:39).
- previous version (September 14, 2017 - 12:35).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
Statistics from Altmetric.com
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Thomas A. Hope, Jeremy Z. Goodman, Isabel E. Allen, Jeremie Calais, Wolfgang P. Fendler, Peter R. CarrollJournal of Nuclear Medicine 2019 60 6
- Stefano Fanti, Karolien Goffin, Boris A Hadaschik, Ken Herrmann, Tobias Maurer, Steven MacLennan, Daniela E. Oprea-Lager, Wim JG Oyen, Olivier Rouvière, Nicolas Mottet, Anders BjartellEuropean Journal of Nuclear Medicine and Molecular Imaging 2021 48 2
- Edouard J. Trabulsi, R. Bryan Rumble, Hossein Jadvar, Thomas Hope, Martin Pomper, Baris Turkbey, Andrew B. Rosenkrantz, Sadhna Verma, Daniel J. Margolis, Adam Froemming, Aytekin Oto, Andrei Purysko, Matthew I. Milowsky, Heinz-Peter Schlemmer, Matthias Eiber, Michael J. Morris, Peter L. Choyke, Anwar Padhani, Jorge Oldan, Stefano Fanti, Suneil Jain, Peter A. Pinto, Kirk A. Keegan, Christopher R. Porter, Jonathan A. Coleman, Glenn S. Bauman, Ashesh B. Jani, Jeffrey M. Kamradt, Westley Sholes, H. Alberto VargasJournal of Clinical Oncology 2020 38 17
- Steven P. Rowe, Kenneth J. Pienta, Martin G. Pomper, Michael A. GorinEuropean Urology 2018 73 4
- Frédéric E Lecouvet, Daniela E Oprea-Lager, Yan Liu, Piet Ost, Luc Bidaut, Laurence Collette, Christophe M Deroose, Karolien Goffin, Ken Herrmann, Otto S Hoekstra, Gem Kramer, Yolande Lievens, Egesta Lopci, David Pasquier, Lars J Petersen, Jean-Noël Talbot, Helle Zacho, Bertrand Tombal, Nandita M deSouzaThe Lancet Oncology 2018 19 10
- Il Minn, David J. Huss, Hye-Hyun Ahn, Tamara M. Chinn, Andrew Park, Jon Jones, Mary Brummet, Steven P. Rowe, Polina Sysa-Shah, Yong Du, Hyam I. Levitsky, Martin G. PomperScience Advances 2019 5 7
- Stefano Fanti, Boris Hadaschik, Ken HerrmannJournal of Nuclear Medicine 2020 61 5
- Sara Sheikhbahaei, Rudolf A. Werner, Lilja B. Solnes, Kenneth J. Pienta, Martin G. Pomper, Michael A. Gorin, Steven P. RoweSeminars in Nuclear Medicine 2019 49 4
- PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Jeremie Calais, Francesco Ceci, Steve Y. Cho, Stefano Fanti, Frederik L. Giesel, Karolien Goffin, Uwe Haberkorn, Heather Jacene, Phillip J. Koo, Klaus Kopka, Bernd J. Krause, Liza Lindenberg, Charles Marcus, Felix M. Mottaghy, Daniela E. Oprea-Lager, Joseph R. Osborne, Morand Piert, Steven P. Rowe, Heiko Schöder, Simon Wan, Hans-Jürgen Wester, Thomas A. Hope, Ken HerrmannEuropean Journal of Nuclear Medicine and Molecular Imaging 2023 50 5
- Wojciech Cytawa, Anna Katharina Seitz, Stefan Kircher, Kazuhito Fukushima, Johannes Tran-Gia, Andreas Schirbel, Tomasz Bandurski, Piotr Lass, Markus Krebs, Wojciech Połom, Marcin Matuszewski, Hans-Jürgen Wester, Andreas K. Buck, Hubert Kübler, Constantin LapaEuropean Journal of Nuclear Medicine and Molecular Imaging 2020 47 1
Article usage
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 3
March 1, 2018
Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen–Targeted PET Imaging: PSMA-RADS Version 1.0
Steven P. Rowe, Kenneth J. Pienta, Martin G. Pomper, Michael A. Gorin
Journal of Nuclear Medicine Mar 2018, 59 (3) 479-485; DOI: 10.2967/jnumed.117.195255
Jump to section
Related Articles
Cited By...
- Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
- Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
- Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
- An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
- Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
- Liver Enzyme Elevation After 177Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
- Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer
- Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria
- Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
- Comparison of 3 Interpretation Criteria for 68Ga-PSMA11 PET Based on Inter- and Intrareader Agreement
- Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer
- An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application
- Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
- Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
- Improving 68Ga-PSMA PET/MRI of the Prostate with Unrenormalized Absolute Scatter Correction
- Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
- Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology
- Novel Structured Reporting Systems for Theranostic Radiotracers
- Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories
- Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging
- SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
- Proposed Criteria Positions PSMA PET for the Future